Drug Type Small molecule drug |
Synonyms 3-O-caffeoylquinic-acid, 3-caffeoylquinic-acid, Coffee tannic acid + [1] |
Target |
Mechanism LAG3 inhibitors(Lymphocyte activation gene 3 protein inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationSpecial Review Project (CN) |
Molecular FormulaC16H18O9 |
InChIKeyCWVRJTMFETXNAD-NCZKRNLISA-N |
CAS Registry327-97-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Chlorogenic acid | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Lung Squamous Cell Carcinoma | Phase 1 | CN | 12 Sep 2018 | |
Kidney Neoplasms | Phase 1 | CN | 24 Oct 2014 | |
Liver Cancer | Phase 1 | CN | 24 Oct 2014 | |
Glioblastoma | Preclinical | CN | 27 Nov 2018 | |
Glioblastoma Multiforme | Preclinical | CN | 27 Nov 2018 | |
Small Cell Lung Cancer | Preclinical | CN | 15 Nov 2018 | |
Lung Cancer | Preclinical | CN | 17 Jul 2018 | |
Non-Small Cell Lung Cancer | Preclinical | CN | 05 Jul 2018 | |
Advanced cancer | Preclinical | - | 01 May 2014 | |
Advanced cancer | Preclinical | - | 01 May 2014 |
Phase 2 | 30 | Placebo (Placebo) | (cpjfbfmzqc) = immvlifgoe zyoxgamfpd (kfrgnhzmzr, kjwxjlunkq - vxvksthzsn) View more | - | 02 Aug 2019 | ||
(Chlorogenic Acid) | (cpjfbfmzqc) = dyqmlffohb zyoxgamfpd (kfrgnhzmzr, owovvyzsyk - nyhdcyusoc) View more |